Combarros Onofre, García-Román Marisa, Fontalba Ana, Fernández-Luna José L, Llorca Javier, Infante Jon, Berciano José
Unit of Neurology, 'Marqués de Valdecilla' University Hospital, University of Cantabria, Spain.
Dement Geriatr Cogn Disord. 2003;15(3):151-4. doi: 10.1159/000068480.
The H63D mutation in the hemochromatosis gene (HFE) has recently been considered as a risk factor in Alzheimer's disease (AD) with advancing age at onset of the disease, independently of the apolipoprotein E (ApoE) epsilon4 allele effect. We examined the distribution of the H63D mutation and ApoE genotypes as a function of age at AD onset in 328 patients with sporadic AD. Our data show that the mutant H63D allele potentially interacts with the ApoE epsilon4 allele to significantly reduce age at onset of AD compared to ApoE epsilon4 carriers alone, but has no effect on age at onset in ApoE epsilon4 non-carriers.
血色素沉着症基因(HFE)中的H63D突变最近被认为是阿尔茨海默病(AD)的一个风险因素,与发病年龄的增长有关,且独立于载脂蛋白E(ApoE)ε4等位基因效应。我们在328例散发性AD患者中,研究了H63D突变和ApoE基因型随AD发病年龄的分布情况。我们的数据显示,与仅携带ApoE ε4的携带者相比,突变的H63D等位基因可能与ApoE ε4等位基因相互作用,显著降低AD的发病年龄,但对非ApoE ε4携带者的发病年龄没有影响。